Filing Details

Accession Number:
0000884905-10-000049
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-08-03 13:00:00
Reporting Period:
2010-07-30
Filing Date:
2010-08-03
Accepted Time:
2010-08-03 15:13:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884905 Praxair Inc PX Industrial Inorganic Chemicals (2810) 061249050
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1411350 F Eduardo Menezes C/O Praxair, Inc.
30 Old Ridgebury Road
Danbury CT 06810-5113
Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-07-30 14,000 $36.58 22,270 No 4 M Direct
Common Stock Disposition 2010-07-30 14,000 $84.91 8,270 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2010-07-30 14,000 $0.00 14,000 $36.58
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2005-02-24 2014-02-24 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,541 Indirect 401(k)
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $44.25 2006-02-22 2015-02-22 23,000 23,000 Direct
Common Stock Stock Option (right to buy) $53.98 2007-02-28 2016-02-29 25,000 25,000 Direct
Common Stock Stock Option (right to buy) $61.47 2008-02-27 2017-02-27 25,000 25,000 Direct
Common Stock Stock Option (right to buy) $83.89 2009-02-26 2018-02-26 16,000 16,000 Direct
Common Stock Stock Option (right to buy) $83.89 2011-02-26 2018-02-26 9,000 9,000 Direct
Common Stock Stock Option (right to buy) $60.92 2010-02-24 2019-02-24 31,130 31,130 Direct
Common Stock Stock Option (right to buy) $76.16 2011-02-23 2020-02-23 19,610 19,610 Direct
Common Stock Deferred Stock $0.00 151 151 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2015-02-22 23,000 23,000 Direct
2016-02-29 25,000 25,000 Direct
2017-02-27 25,000 25,000 Direct
2018-02-26 16,000 16,000 Direct
2018-02-26 9,000 9,000 Direct
2019-02-24 31,130 31,130 Direct
2020-02-23 19,610 19,610 Direct
151 151 Direct
Footnotes
  1. This total includes shares previously acquired through automatic dividend reinvestment under the Praxair Dividend Reinvestment and Stock Purchase Plan.
  2. The $84.9083 price reported is the weighted average sale price. The sale prices ranged from $84.82 to $85.02 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
  3. This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
  4. This option vests over three years in three consecutive equal annual installments beginning on February 26, 2009.
  5. This option will vest in full if Praxair, Inc. achieves cumulative fiscal year earnings per share growth of at least 33% over 2007 earnings per share at any time prior to January 1, 2011. If vested, the option may be exercised beginning on the third anniversary of the grant date. If Praxair, Inc. fails to meet the cumulative earnings per share goal, this option will be forfeited.
  6. This option vests over three years in three consecutive equal annual installments beginning on February 24, 2010.
  7. This option vests over three years in three consecutive equal annual installments beginning on February 23, 2011.
  8. Conversion to Praxair Common Stock is on a 1-for-1 basis.
  9. Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Program as amended ("Deferred Program") and are to be settled in Praxair Common Stock.